Glukosaminsulfat og hyperkolesterolæmi
- Conditions
- Osteoarthritis
- Registration Number
- EUCTR2005-000541-11-DK
- Lead Sponsor
- Slidgigtinstituttet A/S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Patients do understand the studyprotocol (popular edition)
Symptoms of osteoarthritis.
40 years or older.
No intake of glucosamine for at least 3 months.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Severe illness (fx heart disease, cancer, inflammation illnesses as fx cronic Rheumatoid arthritis).
Medicine (other than painkillers as paracetamol and NSAID)
Change or planing a change in diet or physical activity
Abuse of alcohol
Pregnant or nursing
Allergy to shellfish
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Investigate the effect of glucosamine supplementation on lipoproteins (cholesterol) and triglycerides in patients with mild to moderate osteoarthritis.;Secondary Objective: Symptom change<br>Adverse effects;Primary end point(s): Cholesterol and triglyceride concentration in the blood.
- Secondary Outcome Measures
Name Time Method